ETC
CRL icon

Exchange Traded Concepts’s Charles River Laboratories CRL Stock Holding History

Exchange Traded Concepts’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
5,640
+58
+1% +$10.3K 0.01% 850
2026
Q1 		$963K Buy
5,582
+121
+2% +$22.4K 0.01% 825
2025
Q4 		$1.09M Sell
5,461
-263
-5% -$47.7K 0.01% 768
2025
Q3 		$896K Sell
5,724
-18
-0.3% -$2.86K 0.01% 814
2025
Q2 		$871K Buy
5,742
+76
+1% +$10.1K 0.01% 728
2025
Q1 		$853K Sell
5,666
-253
-4% -$42.4K 0.01% 609
2024
Q4 		$1.09M Sell
5,919
-130
-2% -$25K 0.02% 530
2024
Q3 		$1.19M Buy
6,049
+1,264
+26% +$263K 0.03% 457
2024
Q2 		$988K Buy
4,785
+473
+11% +$107K 0.03% 439
2024
Q1 		$1.17M Sell
4,312
-1,152
-21% -$275K 0.03% 410
2023
Q4 		$1.29M Sell
5,464
-1,766
-24% -$347K 0.03% 345
2023
Q3 		$1.42M Sell
7,230
-1,840
-20% -$378K 0.04% 293
2023
Q2 		$1.91M Buy
9,070
+1,921
+27% +$382K 0.05% 276
2023
Q1 		$1.44M Sell
7,149
-607
-8% -$138K 0.04% 258
2022
Q4 		$1.69M Sell
7,756
-547
-7% -$119K 0.05% 210
2022
Q3 		$1.63M Buy
8,303
+1,127
+16% +$243K 0.05% 173
2022
Q2 		$1.53M Sell
7,176
-828
-10% -$202K 0.04% 208
2022
Q1 		$2.27M Sell
8,004
-3,099
-28% -$956K 0.05% 207
2021
Q4 		$4.18M Buy
11,103
+1,387
+14% +$539K 0.08% 148
2021
Q3 		$4.01M Sell
9,716
-1,334
-12% -$554K 0.1% 127
2021
Q2 		$4.09M Sell
11,050
-197
-2% -$65.8K 0.13% 111
2021
Q1 		$3.26M Buy
11,247
+3,840
+52% +$1.07M 0.12% 116
2020
Q4 		$1.85M Buy
7,407
+4,096
+124% +$975K 0.09% 158
2020
Q3 		$750K Buy
3,311
+1,195
+56% +$248K 0.04% 199
2020
Q2 		$369K Buy
2,116
+1,082
+105% +$173K 0.06% 256
2020
Q1 		$131K Buy
1,034
+383
+59% +$57.4K 0.07% 235
2019
Q4 		$99K Buy
+651
New +$90.1K 0.02% 195

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Exchange Traded Concepts's CRL Position: Q2 2026 in Review

Exchange Traded Concepts increased its Charles River Laboratories (CRL) stake by 1% in Q2 2026, buying an estimated $10.3K and bringing the position to 5,640 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #850.

Exchange Traded Concepts first reported a position in CRL in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.18M in Q4 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Exchange Traded Concepts held 5,640 shares of Charles River Laboratories worth $1.28M as of Q2 2026.
  • Exchange Traded Concepts bought 58 Charles River Laboratories shares in Q2 2026, an estimated $10.3K.
  • Charles River Laboratories made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #850 holding.
  • Exchange Traded Concepts first reported a position in Charles River Laboratories in Q4 2019 and has held it in 27 quarters since.
  • Exchange Traded Concepts's Charles River Laboratories position peaked at $4.18M in Q4 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.